Literature DB >> 10752809

Energy expenditure in acetaminophen-induced fulminant hepatic failure.

T S Walsh1, S J Wigmore, P Hopton, R Richardson, A Lee.   

Abstract

OBJECTIVE: To determine energy expenditure in critically ill patients suffering from acetaminophen-induced fulminant hepatic failure and compare it with values obtained in matched, healthy control subjects and in patients studied during the anhepatic period of elective liver transplantation.
DESIGN: Prospective, controlled, observational study.
SETTING: A ten-bed intensive therapy unit and a liver transplant unit at a University teaching hospital. PATIENTS AND
SUBJECTS: Sixteen patients suffering from acetaminophen-induced fulminant hepatic failure who were sedated, paralyzed, and mechanically ventilated; 16 age-, gender-, and weight-matched, awake, healthy control subjects; and 16 patients with chronic liver disease, undergoing elective liver transplantation, who were studied during the anhepatic period of surgery.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The mean energy expenditure was calculated in each case for a 30-min period, using indirect calorimetry. In the patients undergoing liver transplantation, measurements were performed after clamping the hepatic veins and recipient hepatectomy. Energy expenditure was markedly increased in the fulminant hepatic failure group (mean energy expenditure, 4.05 [SD 0.52] kJ x kg(-1) x hr(-1)), in comparison with healthy control subjects (mean, 3.44 [0.27] kJ x kg(-1) x hr(-1); mean difference, 18%; p < .001) and in comparison with patients during the anhepatic period of liver transplantation (mean, 3.15 [0.61] kJ x kg(-1) x hr(-1); mean difference, 29%; p < .001). These differences were even more pronounced when a correction factor for differences in core temperature was included in the calculation. Harris-Benedict predictions of energy expenditure were unreliable in the patients with acute liver failure. No correlations were found among energy expenditure and hemodynamic variables, the requirement for vasoconstrictors, or the presence of renal failure.
CONCLUSIONS: Despite the loss of functioning liver cell mass, the metabolic rate is substantially increased in patients with acetaminophen-induced fulminant hepatic failure. This finding is consistent with the marked systemic inflammatory response, which accompanies acute hepatic failure. The Harris-Benedict equation is unreliable when an estimation of energy expenditure is required in patients with this condition.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10752809     DOI: 10.1097/00003246-200003000-00008

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  13 in total

1.  TGFβ1 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5.

Authors:  Matthew A McMillin; Gabriel A Frampton; Andrew P Seiwell; Nisha S Patel; Amber N Jacobs; Sharon DeMorrow
Journal:  Lab Invest       Date:  2015-06-01       Impact factor: 5.662

2.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 3.  [Acute liver failure. How much diagnostic work-up and therapy does my patient need?].

Authors:  J Hadem; A S Schneider; M P Manns
Journal:  Internist (Berl)       Date:  2011-07       Impact factor: 0.743

4.  Acute Liver Failure.

Authors:  J Eileen Hay
Journal:  Curr Treat Options Gastroenterol       Date:  2004-12

5.  Ketone Body Therapy Protects From Lipotoxicity and Acute Liver Failure Upon Pparα Deficiency.

Authors:  Michal Pawlak; Eric Baugé; Fanny Lalloyer; Philippe Lefebvre; Bart Staels
Journal:  Mol Endocrinol       Date:  2015-06-18

Review 6.  Hypothermia for the management of intracranial hypertension in acute liver failure.

Authors:  Rajiv Jalan; Nathan A Davies; Steven W M Olde Damink
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

Review 7.  [Nutrition and liver failure].

Authors:  M Plauth
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-05-18       Impact factor: 0.840

8.  Measurement of Total Liver Volume Using the Energy Expenditure: A New Formula.

Authors:  Matteo Donadon; Antonio Mimmo; Guido Costa; Matteo Cimino; Luca Viganò; Angela Palmisano; Guido Torzilli
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

9.  Fulminant hepatic failure.

Authors:  Jelica Kurtovic; Stephen M Riordan; Roger Williams
Journal:  Curr Treat Options Gastroenterol       Date:  2005-12

Review 10.  Hepatology - Guidelines on Parenteral Nutrition, Chapter 16.

Authors:  M Plauth; T Schuetz
Journal:  Ger Med Sci       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.